ECOR
electroCore, Inc. Common Stock
stockNASDAQ
electrocore is, a us based electroceutical healthcare company, which is developing a range of non-invasive vagus nerve stimulation (nvns) patient administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and other fields. initial focus is on primary headache (migraine and cluster headache), with trials continuing in epilepsy, gastric motility disorders, depression and anxiety. electrocore, which was founded in 2005, has more than 30 employees and full time consultants with offices in the us (head office), germany (german and european head office), uk, italy, australia, and canada.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 11.03 | 2026-09-28 | -8.02% | -1.077 |
| 1M | 9.21 | 2026-09-04 | +10.15% | 1.737 |
| 3M | 8.28 | 2026-07-06 | +22.52% | 1.775 |
| 6M | 7.04 | 2026-04-06 | +44.10% | 1.113 |
| 1Y | 5.01 | 2025-10-06 | +102.50% | 1.756 |
| 2Y | 7.35 | 2024-10-04 | +38.03% | — |
| 5Y | 15.45 | 2021-10-05 | -34.34% | 0.845 |
electroCore, Inc. Common Stock (NASDAQ:ECOR) stock price today is $10.15, and today's volume is 122,250. ECOR is down 1.648% today. The 30 day average volume is 84,507. ECOR market cap is $91.47M with 9.02M shares outstanding.